Jun 7 2010
Inverness Medical Innovations, Inc. (NYSE: IMA) announced today that it has further extended its offer to exchange up to $100,000,000 in aggregate principal amount of 7.875% Senior Notes due 2016 (the "Notes") that have been registered under the Securities Act of 1933, as amended, for a like principal amount of its outstanding unregistered 7.875% Senior Notes due 2016, to 5:00 p.m., New York City time, on Friday, June 11, 2010, unless further extended.
The terms and conditions of the exchange offer are set forth in Inverness's prospectus dated April 21, 2010.
The exchange offer had been scheduled to expire at 5:00 p.m., New York City time, on Friday, June 4, 2010. Inverness has been advised that, as of that time, $98,000,000 in aggregate principal amount, or approximately 98% of the aggregate principal amount, of outstanding unregistered 7.875% Senior Notes due 2016 had been validly tendered to the exchange agent by the holders thereof, including by means of guaranteed delivery.
The exchange agent for the offer is The Bank of New York Mellon Trust Company, N.A., Corporate Trust Operations, Reorganization Unit, 101 Barclay Street — 7 East, New York, NY 10286, Attn: Carolle Montreuil, (212) 815-5920.
Source:
Inverness Medical Innovations, Inc.